DAIICHI SANKYO and Eli Lilly and Company

LONDON - Britons First to Benefit From Latest Heart Tablet Prasugrel (Efient(R) Black Triangle Drug) UK patients are the first to benefit from the launch of a new heart drug prasugrel (Efient), following authorisation by the European Medicines Agency (EMEA).